Disparities in child and adolescent COVID-19 vaccination coverage and parental intent toward vaccinations for their children and adolescents

Annals of Medicine, Год журнала: 2023, Номер 55(1)

Опубликована: Июль 14, 2023

Despite recommendations for COVID-19 primary series completion and booster doses children adolescents, coverage has been less than optimal, particularly in some subpopulations. This study explored disparities childhood/adolescent vaccination, parental intent to vaccinate their reasons non-vaccination the US.Using U.S. Census Bureau's Household Pulse Survey (HPS), we analyzed households with aged <18 years using data collected from September 14 November 14, 2022 (n = 44,929). Child adolescent vaccination (≥1 dose, completed series, vaccination) intentions toward were assessed by sociodemographic characteristics. Factors associated child examined multivariable regression models. Reasons overall, child's age group respondent's group.Overall, approximately half (50.1%) of < 18 vaccinated against dose). Completed was 44.2% among all years. By group, 13.2% <5 years, 43.9% 5-11 63.3% adolescents 12-17 Booster those who 39.1% 55.3% Vaccination differed race/ethnicity, educational attainment, household income, region, status, prior diagnosis, group. Parental reluctance highest (46.8%). Main reluctant parents concerns about side effects (53.3%), lack trust vaccines (48.7%), belief that do not need a vaccine (38.8%).Disparities continue exist. Further efforts are needed increase confidence vaccines.Using survey 2022, low adolescents. Overall, 5–11 12–17 years.Vaccination child’s group.Parental (46.8%), followed (35.8%) (23.5%).Main (38.8%), government (35.6%), members high-risk (32.8%).Disparities vaccines.

Язык: Английский

---

Parental hesitancy about COVID-19, influenza, HPV, and other childhood vaccines

Vaccine, Год журнала: 2024, Номер 42(25), С. 126139 - 126139

Опубликована: Июль 17, 2024

Язык: Английский

---

Factors associated with parental COVID-19 vaccine attitudes and intentions among a national sample of United States adults ages 18–45

Journal of Pediatric Nursing, Год журнала: 2023, Номер 69, С. 108 - 115

Опубликована: Янв. 20, 2023

Язык: Английский

---

Sociodemographic differences in parental hesitancy to the COVID-19 vaccine

Vaccine, Год журнала: 2025, Номер 55, С. 127041 - 127041

Опубликована: Март 24, 2025

Язык: Английский

---

A scoping review protocol on childhood immunization reminder strategies available to parents in Canada and the United States of America

PLoS ONE, Год журнала: 2025, Номер 20(5), С. e0323186 - e0323186

Опубликована: Май 22, 2025

Introduction Vaccine-preventable diseases continue to cause morbidity and mortality despite the introduction of childhood immunizations. Recent media reports from Canada United States America (USA) have highlighted a rise in illnesses like measles, which could been prevented with vaccines. Parents play pivotal role ensuring their children receive timely vaccinations. Immunization reminders can help parents who forget or miss vaccination appointments. In USA, current literature indicates that Black lower rates than other racialized vaccine may improve measles uptake among parents. However, there is limited data on parents, evidence suggesting hesitancy population. Objective This scoping review aims map out existing immunization reminder strategies identify impact improving promoting child health. Inclusion criteria The will include studies conducted focus for under six years published English between 2015 2025. Methods Database hand-searching journals gray be carried retrieve pertinent articles. Studies meet inclusion eligible selection. process selecting then summarized PRISMA-ScR chart. Collated data-extraction tables authorship information, publication date, methods findings. findings, key arguments themes analyzed using thematic analysis narrative summary. Conclusion contribute knowledge parental preferences usefulness increasing rates. findings inform public health aimed at boosting children.

Язык: Английский

---

COVID-19 vaccination attitudes, values, intentions: US parents for their children, September 2021

Vaccine, Год журнала: 2023, Номер 41(49), С. 7395 - 7408

Опубликована: Ноя. 1, 2023

Язык: Английский

---

An overview of the COVID-19 pediatric vaccine program – The U.S. experience vaccinating children ages 6 months through 17 years

Vaccine, Год журнала: 2024, Номер 42, С. 125702 - 125702

Опубликована: Фев. 29, 2024

COVID-19 vaccination decreases risk for illness and severe disease in children, including multisystem inflammatory syndrome (MIS-C) death. On December 13, 2020, CDC recommended persons ages ≥16 years, with expansion on May 12, 2021, to adolescents 12-15 years; children 5-11 years November 2, 2021; 6 months-4 June 18, 2022. Following each age-specific recommendation, the U.S. government collaborated state local governments, vaccine manufacturers, numerous other public private entities, ensure rapid, broad, equitable distribution strategic locations across country maximize access. However, coverage among has been lower than adults younger adolescents. As of 10, 2023, primary series was 61.8% 12-17 32.9% those 5.5% years. This manuscript describes planning implementation pediatric program, successes (e.g., availability pharmacy extend access beyond more traditional providers) challenges multi-dose vials instead single-dose vials, leading concerns about wastage) provide a historical record program help inform future routine or pandemic-related campaigns.

Язык: Английский

---

Spatial Accessibility and Uptake of Pediatric COVID-19 Vaccinations by Social Vulnerability

PEDIATRICS, Год журнала: 2024, Номер 154(2)

Опубликована: Июль 19, 2024

BACKGROUND AND OBJECTIVES Geographic accessibility predicts pediatric preventive care utilization, including vaccine uptake. However, spatial inequities in the coronavirus disease 2019 (COVID-19) vaccination rollout remain underexplored. We assessed of sites and analyzed predictors METHODS In this cross-sectional study COVID-19 vaccinations from US Vaccine Tracking System as July 29, 2022, we described by geocoding sites, measuring travel times each Census tract population center to nearest site, weighting tracts their demographics obtain nationally representative estimates. used quasi-Poisson regressions calculate incidence rate ratios, comparing uptake between counties with highest lowest quartile Social Vulnerability Index scores: socioeconomic status (SES), household composition disability (HCD), minority language (MSL), housing type transportation. RESULTS 15 233 956 doses administered across 27 526 sites. Rural, uninsured, white, Native American populations experienced longer site than urban, insured, Hispanic, Black, Asian populations. Overall Index, SES, HCD were associated decreased among children aged 6 months 4 years (overall: ratio 0.70 [95% confidence interval 0.60–0.81]; SES: 0.66 [0.58–0.75]; HCD: 0.38 [0.33–0.44]) 5 11 0.85 [0.77–0.95]; 0.71 [0.65–0.78]; 0.67 [0.61–0.74]), whereas social vulnerability MSL was increased (6 months–4 years: 5.16 [3.59–7.42]; years–11 1.73 [1.44–2.08]). CONCLUSIONS Pediatric differed race, rurality, vulnerability. National supply data, measurement, place-based indices can be applied throughout public health resource allocation, surveillance, research.

Язык: Английский

---

Neutralization of SARS-CoV-2 Omicron BQ.1, BQ.1.1 and XBB.1 variants following SARS-CoV-2 infection or vaccination in children

Nature Communications, Год журнала: 2023, Номер 14(1)

Опубликована: Дек. 1, 2023

Emergence of highly transmissible Omicron subvariants led to increased SARS-CoV-2 infection and disease in children. However, minimal knowledge exists regarding the neutralization capacity against circulating BA.4/BA.5, BA.2.75, BQ.1, BQ.1.1 XBB.1 following vaccination children versus during acute or convalescent COVID-19, multisystem inflammatory syndrome (MIS-C). Here, we evaluate virus-neutralizing variants 151 age-stratified ( <5, 5-11, 12-21 years old) hospitalized with severe COVID-19 MIS-C mild (outpatient) compared 62 vaccinated An age-associated effect on neutralizing antibodies is observed vaccination. The primary series BNT162b2 mRNA adolescents show higher vaccine-homologous WA-1 titers <12 Post-infection did not neutralize subvariants. In contrast, monovalent induces more cross-neutralizing young <5 ≥5 old Our study demonstrates that children, vaccination-induced activity low variants. These findings suggest a need for improved vaccines induce durable, cross-reactive provide effective protection emerging

Язык: Английский

---

Evolution of the Antigenic Landscape in Children and Young Adults with COVID-19 and MIS-C

Vaccines, Год журнала: 2024, Номер 12(6), С. 638 - 638

Опубликована: Июнь 7, 2024

There is minimal knowledge regarding the durability of neutralization capacity and level binding antibody generated against highly transmissible circulating Omicron subvariants following SARS-CoV-2 infection in children with acute COVID-19 those diagnosed multisystem inflammatory syndrome (MIS-C) absence vaccination. In this study, titers ancestral strain (WA1) sublineages were evaluated unvaccinated admitted for (n = 32) MIS-C at time hospitalization (baseline) six to eight weeks post-discharge (follow-up) between 1 April 2020, September 2022. addition, spike receptor domain (RBD) from WA1, BA.1, BA.2.75, BA.4/BA.5 was determined using surface plasmon resonance (SPR). At baseline, demonstrated two-fold three-fold higher neutralizing antibodies WA1 compared COVID-19. Importantly, COVID-19, virus reached same as had baseline but than 6–8 cases. Cross-neutralization recently emerged BQ.1, BQ.1.1, XBB.1 variants very low either or all points. These findings about post-infection immunity suggest need vaccinations prior provide effective protection emerging variants.

Язык: Английский

---